Posts tagged “GSK”
GSK has struck a development agreement with Idera Pharmaceuticals, Inc., which develops drugs for patients with renal disease. The deal comes with an up-front payment of $2.5 million to Idera, and is worth as much as $100 million.
GSK today announced the ten Triangle-area nonprofits that will receive $40,000 each to build healthy communities by tackling employment, housing, literacy, and other pressing community health challenges.
GlaxoSmithKline, one of the Research Triangle's largest employers, saw increased sales in the third quarter that beat analysts estimates in the thrid quarter despite declining profits. It reported sales of $9.4 billion in the quarter, up 11 percent over the same period last year, but profits declined to $2.6 billion, a 5 percent drop.
A closely watched study of GlaxoSmithKline plc's Breo Ellipta respiratory treatment failed to prove that it extends patients' lives, denying the drugmaker a much-needed marketing edge in its most lucrative - but declining - medicine category.
GlaxoSmithKline has struck another major deal with Novartis. This time the drug giants are teaming up for a deal worth more than $1 billion plus royalties to GSK for an experimental multiple sclerosis drug. The deal will help GSK focus on other priorities, a top executive says.
Bezos disputes critical Amazon story; GSK plant reopens; Lenovo's new storage move; report links AT&T, NSA
In today's Bulldog wrapup of technology and life science news: Jeff Bezos disputes a New York Times story critical of the company's work environment; GSK reopens its plant in Zebulon; Lenovo launches a new storage product; and a New York Times report links AT&T with the NSA.
Pfizer-GSK rumors; Apple ups hiring of women, minorities; Dell's new Chromebooks; Pure Storage IPO; Tesla raising $500M
In today's wrapup of technology and life science news: Rumors heat up that Pfizer wants GSK; Apple reports big increase in hiring of women and minorities; Dell's new Chromebooks; EMC, NetApp rival Pure Storage eyes IPO; and Tesla aims to raise $500 million.
Pharmaceutical company GlaxoSmithKline (NYSE: GSK) anticipates resuming production at its Zebulon site in the next three days after bacteria that causes Legionnaires' disease was found in the cooling towers, a company spokesperson said Wednesday.
Phoundry Pharmaceuticals, a startup spun out from GlaxoSmithKline, has found eight investors and is looking for more as it aims to raise $1 million. The firm is targeting diabetes. It's also already backed by the N.C. Biotechnology Center.
Takeover talk sparks GSK shares; AT&T workers' contract expires; Tesla's cash burn; Buffet's bad quarter
In today's Bulldog wrapup of technology and life science news: GlaxoSmithKline shares are climbing on takeover talk; AT&T workers in southeast are without a contract; Tesla is burning $4,000 in cash for very car sold; and a bad quarter for Warren Buffet's investments.
GSK rehires China exec; automakers buy Nokia map biz; Yahoo buys style-tip site; Zuckerbergs expecting; Windows 10 scam warning
In today's wrapup of technology and life science news: GSK has rehired an executive linked to its China bribery scandal; German automakers are buying Nokia's map business in a step toward driverless cars; Yahoo buys a web startup; the Zuckerbergs are expecting; and a warning about a free Windows update scam.
In a conference call, GlaxoSmithKline's top executive is asked if he would consider "pairing up" with another drug company. Back in May, an analyst started talk of a "PfizerKline" merger. GSK's CEO Andrew Witty notes a merger would be a "big issue to cross."
As many as 200 former GlaxoSmithKline employees who were transferred to life science services firm Parexel earlier this year are reportedly being laid off today. However, the Boston-based company which has a large presence in the Triangle, isn't talking.
Apple stock slides; Microsoft's $8.4B write-down; GSK suit; Yahoo's loss; Facebook loses warrant fight
In today's Bulldog wrapup of technology and life science news: Apple stock tumbles as it stays coy on watch sales; Microsoft takes a huge write-down; GSK sues a software developer; Yahoo reports a quarterly bummer; and Facebook loses in warrant battle.
GSK's HIV drug deal with China; inside IBM's Wimbledon bunker; Red Hat adds SAP to cloud; Tesla sets record; Wi-Fi in Cuba
In today's wrapup of technology and life science news: GSK makes an HIV drug deal with China; going inside IBM's bunker at Wimbledon; Red Hat adds SAP support to cloud services at Amazon; Tesla sets a record for car deliveries; and Cuba gets Wi-Fi hot spots.
Apple Watch forecast cut; robot kills worker; IBM's $1.5B chip deal closes; GSK vaccine, narcolepsy linked; AT&T-DirecTV deal nears OK
In today's Bulldog wrapup of technology and life science news: An analyst says Apple Watch sales are slowing and he cuts forecast; a robot kills a worker in Germany; IBM closes on its $1.5 billion deal to dump its chip business; a GSK drug is linked to narcolepsy outbreak by study; and AT&T reportedly wins Justice Department OK for its DirecTV deal.
- Google to buy solar power from Duke Energy for NC data center
- US economy grew at 2.1 percent rate in third quarter
- Local business booted out by second phase of Hillsborough Street project
- US home prices jump in September by most in more than a year
- NC's chief information officer returning to private sector